Global Irritable Bowel Syndrome (IBS) Market Research Report 2021
Global Irritable Bowel Syndrome (IBS) Market Research Report 2021
Analysis of the Irritable Bowel Syndrome (IBS) Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Irritable Bowel Syndrome (IBS) Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Irritable Bowel Syndrome (IBS) Market Overview:
Global Irritable Bowel Syndrome (IBS) Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Irritable Bowel Syndrome (IBS) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Irritable Bowel Syndrome (IBS) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Irritable Bowel Syndrome (IBS) market in 2020.
Global Irritable Bowel Syndrome (IBS) Market Segmentation
By Type, Irritable Bowel Syndrome (IBS) market has been segmented into:
IBS-D Drug
IBS-C Drug
Others
By Application, Irritable Bowel Syndrome (IBS) market has been segmented into:
Women
Men
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Irritable Bowel Syndrome (IBS) market are:
Valeant Pharmaceuticals
Allergan
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
1. Market Overview of Irritable Bowel Syndrome (IBS)
1.1 Irritable Bowel Syndrome (IBS) Market Overview
1.1.1 Irritable Bowel Syndrome (IBS) Product Scope
1.1.2 Market Status and Outlook
1.2 Irritable Bowel Syndrome (IBS) Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Irritable Bowel Syndrome (IBS) Historic Market Size by Regions (2015-2020)
1.4 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Irritable Bowel Syndrome (IBS) Sales Market by Type (2015-2026)
2.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2015-2020)
2.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2021-2026)
2.3 IBS-D Drug
2.4 IBS-C Drug
2.5 Others
3. Covid-19 Impact Irritable Bowel Syndrome (IBS) Sales Market by Application (2015-2026)
3.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2015-2020)
3.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2021-2026)
3.3 Women
3.4 Men
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Irritable Bowel Syndrome (IBS) Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Irritable Bowel Syndrome (IBS) Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Irritable Bowel Syndrome (IBS) Business
5.1 Valeant Pharmaceuticals
5.1.1 Valeant Pharmaceuticals Company Profile
5.1.2 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Specification
5.1.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Allergan
5.2.1 Allergan Company Profile
5.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Specification
5.2.3 Allergan Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Takeda
5.3.1 Takeda Company Profile
5.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Specification
5.3.3 Takeda Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Sucampo Pharmaceuticals
5.4.1 Sucampo Pharmaceuticals Company Profile
5.4.2 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Specification
5.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 McNeil Consumer Healthcare
5.5.1 McNeil Consumer Healthcare Company Profile
5.5.2 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product Specification
5.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Sebela Pharmaceuticals
5.6.1 Sebela Pharmaceuticals Company Profile
5.6.2 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Specification
5.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Astellas Pharmaceuticals
5.7.1 Astellas Pharmaceuticals Company Profile
5.7.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Specification
5.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 IM HealthScience
5.8.1 IM HealthScience Company Profile
5.8.2 IM HealthScience Irritable Bowel Syndrome (IBS) Product Specification
5.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
6.2 North America Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
7.2 East Asia Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
7.3 East Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
7.4 East Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
8. Europe
8.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
8.2 Europe Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
8.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
8.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
9.2 South Asia Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
9.3 South Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
9.4 South Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
10.2 Southeast Asia Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
10.3 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
10.4 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
11.2 Middle East Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
11.3 Middle East Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
11.4 Middle East Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
12. Africa
12.1 Africa Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
12.2 Africa Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
12.3 Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
12.4 Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
13.2 Oceania Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
13.3 Oceania Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
13.4 Oceania Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
14. South America
14.1 South America Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
14.2 South America Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
14.3 South America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
14.4 South America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Irritable Bowel Syndrome (IBS) Market Size (2015-2026)
15.2 Rest of the World Irritable Bowel Syndrome (IBS) Key Players in North America (2015-2020)
15.3 Rest of the World Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
15.4 Rest of the World Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
16 Irritable Bowel Syndrome (IBS) Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Irritable Bowel Syndrome (IBS) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|